Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The first MRC-DTP Symposium took place on 22 June 2017 in the Richard Doll Building at the Old Road Campus. The symposium was an opportunity for Medical Research Council funded students to network as well as present their research to peers. With sponsorship from Fisher Scientific and the Nuffield Department of Population Health, 52 people attended the symposium.

The MRC DTP Steering Group Chair, Prof. Marella de Bruijn opened the day and the first session featured talks from Ulrike Kuenzel, Soren Thomsen and Josephine Hellberg. The second session, chaired by Paolo Spingardi, brought together Jan Cosgrave, Abigail Enoch and Daniel Alanine. During the lunch break, poster sessions took place allowing researchers to showcase their work in an informal setting whilst providing a basis for discussion and networking. The afternoon had two parallel training sessions- a Managing Your Supervisor workshop led by Afsie Sabokbar, and a CV workshop from Michael Moss of the University of Oxford, Careers Service. The symposium closed with a ‘Speed Science’ session (think speed dating with science) followed by a wine reception.

Symposium3

Symposium participants commented:

“Good opportunity to present work to local and informal audience, good prep for conferences etc. Also interesting breadth of research.”

“The CV workshop was supreme and it was so wonderful networking with fellow MRC students and hearing about their work.

"Interesting to hear about different research being done; interesting to hear more about the MRC-DTP program”

With thanks to the Organising Committee:

Joost van Haasteren
Jessica Valli
Marella de Bruijn
Laura Colling
Marc Rose

Thanks also to Paolo Spingardi who provided assistance on the day. 

 

Similar stories

Oxford-led team given £6.6m to map uncharted networks in the progression of Parkinson’s

A major new $9 million (£6.6 million) project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. It is the only UK-led ASAP project this year, and the first ever to be led by Oxford.

Tamoxifen repurposing study shows no benefit in treating deadly fungal meningitis

Hopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by the results of a clinical trial conducted by University of Oxford researchers and published today in eLife.

Oxford researchers awarded funding to complete community COVID-19 antiviral trial

Researchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford, have today announced that they have been awarded funding through the National Institute for Health Research (NIHR) to work with several UK universities and carry out a first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 who are at higher risk of complications.

New therapeutic targets identified to treat inflammatory bowel disease

Millions of patients with ulcerative colitis or Crohn’s disease, collectively known as inflammatory bowel disease (IBD), are given fresh hope as a new study shows why some of them do not respond to current treatments.

Oxford researchers call for an urgent re-evaluation of “weak” opioid safety profile

A new study associates dispensation doses of tramadol with increased risk of mortality, cardiovascular events, and fractures compared to the use of codeine to treat pain.

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.